Wonderly Plus subscribers can listen to Business Wars daily ad-free right now.

Join Wonderly Plus in the Wondery app or on Apple Podcasts.

How do I cope with waiting for results?

It's all I can think about.

Is the cancer going to come back?

I can't sleep.

How do I stop worrying?

We know what goes through your head when you're living with

cancer. The questions, the anxieties. We understand because we've been there too. If you or

someone you care about has been diagnosed with cancer, McMillan Cancer supports online community

can help from day one. It's a free, safe, online forum for people with cancer to connect anonymously.

No question is too big or too small. With over 80,000 members, we get it. We've been there.

Whatever you need to ask, we're here. To join, search McMillan online community.

Thank you. McMillan Online Community. From Wondry, I'm David Brown, and this is Business Wars Daily on this Thursday, September

14th.

Here on this show, we've been keeping up with a $100 billion weight loss

drug market. Back in 2021, the drug Wigovee was approved for what the FDA called chronic weight

management, the first of its kind to be approved since 2014. And this year, the brand name

OZempic took off. Ever heard of it? While OZempec is not officially approved for

weight loss, it's been prescribed off-label to treat obesity since it was initially approved

for diabetes patients back in 2017. Someaglutide, the active ingredient in both Wagovi and

Ozempic, surged in popularity this year year after a slate of celebrities said they used it for

...